Navigation Links
enter in Biological Technology

First genetically engineered malaria vaccine to enter human trials

Walter and Eliza Hall Institute scientists have created a weakened strain of the malaria parasite that will be used as a live vaccine against the disease. The vaccine, developed in collaboration with researchers from the US, Japan and Canada, will be trialled in humans from early next year. Mala...

Covance to Sell Its Interactive Voice and Web Response Services and Enter Into a Multi-Year Marketing Agreement with Phase Forward

PRINCETON, N.J., July 15 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD ) today announced it has signed an agreement to sell its Interactive Voice & Web Response Services (IVRS/IWRS) business to Phase Forward (Nasdaq: PFWD ). In addition, Covance and Phase Forward have agree...

Mylan Announces Strategic Collaboration with Biocon to Enter the Global Generic Biologics Market

PITTSBURGH, June 29 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL ) today announced that it has executed a definitive agreement with Biocon Limited, a publicly traded company on the Indian stock exchanges, for an exclusive collaboration on the development, manufacturing, supply and commercia...

Glenmark's Novel Molecule for Diabetes, Melogliptin to Enter Phase III Trials

Release Highlights - Melogliptin continues to demonstrate potential to be the best-in-class in achieving glycemic control with low incidence of hypoglycemia and neutral effect on body weight - Global Phase III trials likely to start by end 2009 - IND approved by USFD...

Pioneer Hi-Bred and Beck's Hybrids Enter into Research and Distribution Agreements

Growers Will Benefit From More Seed Options in the Marketplace. Des Moines, Iowa, and Atlanta, Ind. (Vocus) June 17, 2009 –- Pioneer Hi-Bred , a DuPont business, and Beck’s Hybrids today announced they have entered into research and distribution agreeme...

AccuVein and GSABC Enter into Purchasing Agreement for Vein Illumination Device

GSABC to Offer Members AccuVein's AV300 to Help Ease Venipuncture Process UnitedPharma Named Preferred Blood Center Distributor for AccuVein AV300 COLD SPRING HARBOR, N.Y., June 8 /PRNewswire/ -- AccuVein LLC today announced a three-year agreement with Group Services for America's Blood ...

PDI and The Medical Affairs Company Enter Exclusive Strategic Alliance

SADDLE RIVER, N.J. and KENNESAW, Ga., June 3 /PRNewswire-FirstCall/ -- Two leaders in the pharmaceutical contract services industry, PDI, Inc. (Nasdaq: PDII ), a provider of sales and marketing support to U.S. pharmaceutical companies, and The Medical Affairs Company (TMAC(R)), the leading provi...

Morphotek(R), Inc and Lonza Group Ltd Enter Into Manufacturing Services Agreement

Agreement Underscores Morphotek's Commitment to the Development of Farletuzumab for Ovarian Cancer Agreement Highlights Lonza's Ability to Offer Specialty Development and Manufacturing Solutions EXTON, Pa. and BASEL, Switzerland, May 19 /PRNewswire/ -- Morphotek(R), Inc., a subsidiary of...

Nerviano Medical Sciences Receives Approval From the FDA to Enter Phase I Clinical Trials for Their Polo Like Kinase (PLK) Inhibitor

NERVIANO, Italy, May 13 /PRNewswire/ -- The FDA has approved an Investigational New Drug (IND) application by Nerviano Medical Sciences to begin a phase I clinical study with its selective PLK-1 small molecule inhibitor for the treatment of cancer. PLK-1 is a mitotic kinase required for the pr...

Shire and GlaxoSmithKline Enter Agreement to Co-promote VYVANSE(R) (lisdexamfetamine dimesylate) CII for the Treatment of Adults With ADHD

PHILADELPHIA, March 31 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY ), the global specialty biopharmaceutical company, today announced a co-promotion agreement with GlaxoSmithKline plc (NYSE: GSK ) for VYVANSE(R) (lisdexamfetamine dimesylate) capsules CII with the aim of im...

NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions

- Up to $50 Million Potential Milestones plus Double Digit Royalties on Future Sales - - Company to Host Conference Call at 11:00 a.m. ET Today - EMERYVILLE, Calif., March 25 /PRNewswire-FirstCall/ -- NovaBay Pharmaceuticals, Inc. (NYSE Amex: NBY ), a mid-stage biopharmaceutical comp...

Enerkem announces plans to enter the United States with next-generation biofuels project in Mississippi

Project will allow the recycling and conversion of 60% of Three Rivers region's waste material MONTREAL, March 19 /PRNewswire/ - Enerkem Inc., a leading advanced biofuels and green chemicals technology company, today announced its plans to build and operate a second-generation biofuels prod...

Shire to Enter European ADHD Market With the Acquisition of EQUASYM(R) IR and XL

PHILADELPHIA and DUBLIN, February 20 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY ), the global specialty biopharmaceutical company, announces that it has signed an agreement with UCB to acquire the worldwide rights to EQUASYM(R) IR and XL (methylphenidate hydrochloride) (exc...

Romark and Chugai Pharmaceutical Enter Into Exclusive Licensing Agreement for Nitazoxanide in Japan

Chugai Pharmaceutical Gains Rights to Develop and Market Nitazoxanide for the Treatment of Chronic Hepatitis C TAMPA, Fla., Feb. 17 /PRNewswire/ -- Romark Laboratories, a privately held biopharmaceutical company, and Chugai Pharmaceutical Co. Ltd., a member of the Roche Group, today announced...

ConjuChem and Novozymes Enter Long-Term Supply Agreement for Recombumin(R) use in PC-DAC(TM):Exendin-4

- Additional Pipeline Product Agreement Executed to Support ConjuChem's R&D Efforts - MONTREAL and BAGSVAERD, Denmark, Dec. 3 /PRNewswire-FirstCall/ - ConjuChem Biotechnologies Inc. (TSX:CJB) and Novozymes Biopharma UK Ltd., a subsidiary of Novozymes A/S (LSE:NVZ) announce...

IDRI and Immune Design Corp. Enter License Agreement on GLA Vaccine Adjuvant

SEATTLE, Nov. 20 /PRNewswire/ -- IDRI (Infectious Disease Research Institute) and Immune Design Corp. announced today that they have entered into an agreement pursuant to which Immune Design Corp. is granted a worldwide exclusive license for the research, development, and commercialization of IDRI...

MonoSol Rx and Midatech Group Enter Collaboration Agreement to Unite Nanoparticle and Thin Film Drug Delivery Technologies

Potential to Develop New Oral Drug Candidates with Superior Efficacy, Safety, Convenience, and Commercial Potential WARREN, N.J. and OXFORDSHIRE, England, Nov. 3 /PRNewswire/ -- MonoSol Rx, the developers of PharmFilm(R) technology and a drug delivery company specializing in dissolving thin f...

NeoStem, Inc. to Enter the Regenerative Medicine Market in Asia

NEW YORK, Nov. 3 /PRNewswire-FirstCall/ -- NeoStem, Inc. (Amex: NBS ), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, announced today that it has agreed to acquire a Hong Kong corporation, whose wholly-owned subsid...

Lilly and Amylin Enter Into Supply Agreement for Exenatide Once Weekly

Lilly to Pay Amylin $125 Million and Extend $165 Million Line of Credit to Amylin SAN DIEGO and INDIANAPOLIS, Oct. 21 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) and Eli Lilly and Company (NYSE: LLY ) today announced they have entered...

Radiation Therapy Oncology Group and US Oncology Enter Collaboration to Increase Patient Access to National Clinical Trials

Collaboration Brings Cooperative Group Level Radiation Therapy Trials to US Oncology Affiliates' Patients for First Time HOUSTON, Oct. 16 /PRNewswire/ -- The Radiation Therapy Oncology Group (RTOG) and US Oncology, Inc. today announced they have entered into a collaboration to incre...

Neptune Technologies and Marine Life Sciences enter worldwide distribution alliance with Weider Global Nutrition

--First market launch for Neptune Technologies in FUNCTIONAL FOOD market-- LAVAL, QC, Sept. 25 /PRNewswire-FirstCall/ - Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.V.NTB) reported today that it entered a worldwide alliance with Mari...

St. Joseph's Hospital and InNexus Biotechnology Enter Collaborative Partnership

- Focusing on Development of Treatments For Women with Endometriosis - PHOENIX and BRITISH COLUMBIA, Canada, Sept. 19 /PRNewswire-FirstCall/ -- St. Joseph's Hospital and Medical Center, part of Catholic Healthcare West, one of the largest healthcare systems in the West with 42 hospitals in Ar...

TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm

NEW YORK, MUNICH, Germany and AMSTERDAM, Netherlands, Aug. 21 /PRNewswire/ -- Paul Capital Healthcare and SpePharm Holding, B.V., the pan-European specialty pharmaceutical company, today announced that they have entered into a euro 10 million revenue interest acquisition financing agreement to...

Affitech and Omeros Enter Into Antibody Discovery and Development Agreement

SEATTLE and OSLO, Norway, Aug. 19 /PRNewswire/ -- Omeros Corporation, a Seattle-based clinical-stage biopharmaceutical company, and Affitech AS, a Norwegian human antibody therapeutics company, today announced that they have entered into an agreement for the discovery and development of fully ...

Rosetta Genomics Announces Three New Diagnostic Tests to Enter Development

New Development Programs to Include Response Prediction to Ovarian Cancer Treatment, Predicting Risk of Gastric Cancer Recurrence, and Differentiation of Small Cell From Non-Small Cell Lung Cancer In Addition, the Company has Identified Unique microRNA Biomarkers in the Serum of Colon ...

SomaLogic and Otsuka Enter Into Research Collaboration

Focusing On Diagnostic Products and Target Validation BOULDER, Colo., May 9 /PRNewswire/ -- SomaLogic, Inc. announced today that SomaLogic and Otsuka Pharmaceutical Co., Ltd. entered into a collaboration agreement to use SomaLogic's proprietary aptamer technology to discover and devel...

University Hospitals Case Medical Center, Cleveland, USA and Cardialysis BV, Rotterdam, the Netherlands Enter Strategic Alliance to Found Cardialysis Cleveland

CLEVELAND, Illinois and ROTTERDAM, The Netherlands, May 9 /PRNewswire/ -- University Hospitals Case Medical Center and Cardialysis BV today announced that the Companies have the intention to found Cardialysis Cleveland to provide combined clinical drug development and medical imaging services ...

American Oriental Bioengineering and China Aoxing Pharmaceutical Enter Into Strategic Alliance

- Joint Effort to Capitalize on China's Narcotic and Pain-Management Market Opportunity - NEW YORK, April 15 /PRNewswire-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB ), a leading marketer, distributor and manufacturer of pharmaceutical and healthca...

ETEX and LifeNet Health, Inc. Enter Agreement

CAMBRIDGE, Mass., March 3 /PRNewswire/ -- ETEX Corporation, an advanced biomaterials company, announced today that it has entered into a supply agreement with LifeNet Health, Inc. Under the agreement, LifeNet Health will provide ETEX with Demineralized Bone Matrix (DBM) powder to be mixed wi...

Sigma-Aldrich and MorphoSys Enter Into a Collaboration and Licensing Agreement for Recombinant Research Antibodies

AbD Serotec will use proprietary technology to generate antibodies against novel research targets provided by Sigma-Aldrich MUNICH, Germany and ST. LOUIS, Feb. 27 /PRNewswire-FirstCall/ -- Sigma-Aldrich(TM) (Nasdaq: SIAL ) and MorphoSys AG (Frankfurt Stock Exchange: MOR; Prime Stand...

Energy Conversion Devices and United Solar Ovonic Enter Into New $55 Million Secured Credit Facility Agreements

ROCHESTER HILLS, Mich., Feb. 5 /PRNewswire-FirstCall/ -- Energy Conversion Devices, Inc. (ECD) (Nasdaq: ENER ) announced today that its wholly owned subsidiaries, United Solar Ovonic LLC and United Solar Ovonic Corporation, have entered into a new secured revolving credit facility, with an ag...

ChemDiv and Achaogen Enter Into a Discovery Collaboration

SAN DIEGO, Jan. 29 /PRNewswire/ -- ChemDiv, Inc., a leading chemistry-driven global contract research organization, has announced today that it has entered into a discovery collaboration with Achaogen, Inc., South San Francisco, CA. Applying its expertise in medicinal and synthetic chemistry, ...

Chindex's United Family Hospitals and Clinics and NBC Enter into Healthcare Services Agreement

NBC to Have Access to Chindex's Medical Services During its Preparation and Coverage of the Beijing Olympics, August 8-24, 2008 BETHESDA, Md., Jan. 23 /Xinhua-PRNewswire/ -- Chindex International, Inc. (Nasdaq: CHDX ) a leading independent American provider of Western healthcare servic...

Bookham to Enter Biomedical Illumination Market

Proven filter technology to underpin compact LED multiplexing module SANTA ROSA, Calif., Jan. 14 /PRNewswire-FirstCall/ -- Bookham, Inc. (Nasdaq: BKHM ), a leading provider of optical components for industrial applications, is to enter the biomedical market with its ZoroLight(TM) LED multip...

Palomar and Q-MED AB Enter Into International Distribution Agreement

Q-MED AB to distribute Palomar products outside North America BURLINGTON, Mass., Jan. 9 /PRNewswire-FirstCall/ -- Palomar Medical Technologies, Inc. (Nasdaq: PMTI ), a leading researcher and developer of light-based systems for cosmetic treatments, today announced the execution of an int...

Genmab A/S - R1507 Antibody to Enter Phase II Study to Treat Sarcoma

Summary: Genmab's Partner, Roche has Initiated a Phase II study of R1507 for the Treatment of Sarcoma COPENHAGEN, Denmark, December 20 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) announced today that its partner, Roche has initiated a Phase II clinical study of R1507 f...

Good Neighbor Pharmacy Joins with Diversified Racing Solutions to Enter NASCAR Nationwide Series in 2008

Driver Chris Bristol to Pilot Chevrolet Car VALLEY FORGE, Pa., Dec. 17 /PRNewswire/ -- Good Neighbor Pharmacy(R) (GNP) today announced that it has joined with Diversified Racing Solutions (DRS) to enter the NASCAR(R) Nationwide Series in 2008 with the goal of competing in the NAS...

Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001

BALTIMORE, Dec. 14 /PRNewswire/ -- Alba Therapeutics Corporation announced today that it has entered into a strategic collaboration with Shire plc (LSE: SHP, Nasdaq: SHPGY, TSX: SHQ), to jointly develop AT-1001, Alba's lead inhibitor of barrier dysfunction in various gastrointestinal ("GI") di...

STALLERGENES and Protein' eXpert Enter Into a Partnership for Producing Mites Recombinant Allergens

ANTONY, GRENOBLE France, December 13 /PRNewswire-FirstCall/ -- STALLERGENES S.A and Protein'eXpert S.A. announce they have signed a partnership agreement for developing and pharmaceutically producing mites recombinant allergens(1). The partnership is part of the STALLERGENES "Enhanced Allerg...

Fourth Genmab Antibody Developed Under Roche Collaboration to Enter Clinic

Summary: An IND has Been Filed With the FDA for the Fourth Genmab Antibody Developed Under the Company's Collaboration with Roche. COPENHAGEN, December 12 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) announced today that an Investigational New Drug application (IND) for a Genmab antib...
Other Tags
(Date:7/11/2014)... University of Chicago is creating a new professorship ... the University,s Institute for Molecular Engineering and the ... donation from the Millicent and Eugene Bell Foundation., ... reside within the Institute for Molecular Engineering. That ... project at the MBL,s Eugene Bell Center for ...
(Date:7/11/2014)... Shenzhen, China Researchers from Salk Institute for Biological ... time evaluated the safety and reliability of the ... a new method, TALEN-HDAdV, which could significantly increased ... (hiPSC). This study published online in Cell ... for stem cell-based gene therapy. , The combination ...
(Date:7/11/2014)... 2014 The increased risk of kidney injury related ... fluids reflects the mass of HES molecules, according to ... journal of the International Anesthesia Research Society (IARS). , ... effect of HES on cultured human renal proximal tubule ... Wunder and colleagues of University Hospital Wrzburg, Austria. ...
Breaking Biology News(10 mins):New professorship in tissue engineering links molecular engineering, marine biology 2A new genome editing method brings the possibility of gene therapies closer to reality 2In lab studies, hydroxyethyl starch has direct harmful effects on kidney cells 2
(Date:7/12/2014)... Demand Response Management Systems is a crucial peak ... imbalance between energy supply and demand. With the help ... (due to increasing pressure on the grid) and replaced ... residential appliances and thermostats for load reduction. , ... and with government mandates and benefits for energy efficiency ...
(Date:7/12/2014)... 12, 2014 Tylenol lawsuits ( ... move forward in the federal multidistrict litigation underway ... Bernstein Liebhard LLP reports. According to a filing ... F. Stengel has ordered the deposition of a ... found that the witness’s testimony concerning the marketing ...
(Date:7/12/2014)... (HealthDay News) -- Burn injuries increase in the summer as ... burn experts. Among those most vulnerable to these seasonal fire ... and often get burned by putting their hands on the ... the burn unit at Loyola University Medical Center in Maywood, ... adage of ,When you play with fire, you get burned, ...
(Date:7/12/2014)... July 12, 2014 “After my mom’s stroke, she ... a stroke and loss the use of his left side. Eating ... a way to help people like them enjoy eating again,” said ... prototype for the PATRICIA CAROL HALL PLATE (P C H PLATE). ... a more ergonomic way to eat for individuals who suffer from ...
(Date:7/12/2014)... July 12, 2014 With prom shopping ... manufacturer and retailer, is ready to showcase its new ... new collection of evening dresses in its online shop. ... 67% off) for these elegant gowns. According to the ... end on July 26, 2014. , He says, ...
Breaking Medicine News(10 mins):Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 4Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 2Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 3Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 4Health News:Burn Injuries More Common in Summer 2Health News:VogueQueen.com Updates Its Summer Collection With New And Trendy Evening Dresses 2
Other Contents